News | April 01, 2026
Merck completes acquisition of JSR Life Sciences’ chromatography business
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The new assay consolidates screening for four major viral threats into a single workflow
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The presentations underscore the company’s deep expertise in dermatology and immunology
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
Subscribe To Our Newsletter & Stay Updated
